Home › Funds › Vitruvian Partners LLP › HNGE
Vitruvian Partners LLP position in HNGE
HINGE HEALTH INC · Technology
Vitruvian Partners LLP reported holding 450,000 shares of HNGE (HINGE HEALTH INC) in its Q3 2026 13F filing — a position valued at US$43.8M, representing 38.62% of its reported portfolio and ranking #1 among its reported holdings. Vitruvian Partners LLP has disclosed HNGE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vitruvian Partners LLP's HNGE position evolved
Vitruvian Partners LLP first disclosed a stake in HNGE in Q2 2025 at 1,250,000 shares (US$64.7M). Across 6 filings, Vitruvian Partners LLP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 450,000 shares valued at US$43.8M — a reduction of -56,599 shares quarter over quarter.. Notable position changes include a 59% trim in Q2 2026 (shares rose 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.25M | $64.69M | New |
| Q3 2025 | 1.25M | $61.35M | Hold |
| Q4 2025 | 1.25M | $58.06M | Hold |
| Q1 2026 | 1.25M | $48.20M | Hold |
| Q2 2026 | 506.60K | $42.05M | Reduce |
| Q3 2026 | 450.00K | $43.76M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HNGE and 13F data
HNGE (HINGE HEALTH INC) is a Technology company. 100 other funds we track also report a position in HNGE — the largest reported positions include 11.2 Capital Management, LLC (US$204.6M), Deer Management Co. LLC (US$158.4M), BIT Capital GmbH (US$119.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HNGE
- 11.2 Capital Management, LLC 2.46M sh · $204.57M · Q2 2026
- Deer Management Co. LLC 1.91M sh · $158.42M · Q2 2026
- BIT Capital GmbH 1.22M sh · $118.97M · Q3 2026
- BRAIDWELL LP 1.33M sh · $110.40M · Q2 2026
- Divisadero Street Capital Management, LP 1.29M sh · $107.12M · Q2 2026
- Walleye Capital LLC 1.27M sh · $105.21M · Q2 2026
- OBERWEIS ASSET MANAGEMENT INC/ 855.48K sh · $71.00M · Q2 2026
- Shannon River Fund Management LLC 561.22K sh · $46.58M · Q2 2026
- Tyro Capital Management LLC 435.61K sh · $42.36M · Q3 2026
- RTW INVESTMENTS, LP 500.00K sh · $41.50M · Q2 2026
- EMERALD ADVISERS, LLC 360.05K sh · $35.01M · Q3 2026
- Estuary Capital Management LP 393.27K sh · $32.64M · Q2 2026
More on Vitruvian Partners LLP
FAQ
How long has Vitruvian Partners LLP held HNGE?
Vitruvian Partners LLP has disclosed HNGE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Vitruvian Partners LLP's current position in HNGE?
As of Q3 2026, Vitruvian Partners LLP holds 450.00K shares of HNGE (HINGE HEALTH INC), valued at $43.76M, representing 38.62% of its reported portfolio and ranking #1.
Has Vitruvian Partners LLP been buying or selling HNGE?
In the latest 13F filing (Q3 2026), Vitruvian Partners LLP reduced its position in HNGE.
Which other funds hold HNGE?
Other major institutional holders of HNGE include 11.2 Capital Management, LLC, Deer Management Co. LLC, BIT Capital GmbH, among 100 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.